View navigation

SHARC (Scarborough Coastal Health and Care Research Collaborative)

SHARC was developed from The Scarborough Multiple Long Term Conditions Research Hub launched in January 2022 and is a collaborative initiative between York and Scarborough Teaching Hospitals NHS Foundation Trust, The National Institute for Health Research Yorkshire and Humber Clinical Research Network (NIHR CRN), and the Hull York Medical School (HYMS). The aim of the Hub is to grow and develop clinical research in Scarborough for those experiencing multiple long term conditions with a drive to improve access to research opportunities for its large, under-researched population.

Multi-morbidity has been defined by the National Institute for Health and Care Excellence (NICE) as “the presence of two or more long-term health conditions, which can include: defined physical or mental health conditions, such as diabetes or schizophrenia.”. Professor Chris Whitty, in his 2021 Annual Report titled “Health in Coastal Communities”, aptly described towns such as Scarborough and the importance of tackling these complex health needs.

In Scarborough, there were 1,287 deaths in 2018 for those aged under 75. Nearly three quarters of these deaths fell under three broad causes: 299 (23%) due to cardiovascular diseases; 506 (39%) due to cancer and 136 (11%) due to respiratory diseases.

SHARC aims to better address the health and care needs of our coastal populations through high quality collaborative research with community involvement.

This project is a collaboration co funded between York St John University and York and Scarborough Teaching Hospitals NHS Foundation Trust that bring both academic and clinical expertise in health research

Through the opening of new research studies, grant submissions, and the generation of partnership working SHARC is already contributing towards addressing the above as well as the under recruitment issues in many of the eight NIHR CRN priority areas namely COPD, Asthmas, Diabetes, Cardiovascular Disease and Stroke, all of which are of high prevalence in Scarborough. 


SHARC Development

Long_term_Conditions_Hub (1)Long_term_Conditions_Hub2Long_term_Conditions_Hub3Long_term_Conditions_Hub4

1st April 2023 – 31st March 2024

York & Scarborough

50 research studies open to recruitment


3246 patients recruited into clinical trials